The diligent consulting that your company deserves.

TM RA Consultancy is a distinguished consultancy firm specializing in regulations for Active Pharmaceutical Ingredients (APIs) in Brazil. Let us guide you through the Brazilian API legislation.

businesspeople shaking hands

About us

Facilitating processes. Ensuring health.

Our unwavering commitment to regulatory excellence sets us apart in the industry. We offer tailored solutions for international companies seeking to navigate the stringent regulatory landscape of the API Brazilian market.

Our services

How we will assist you

Our team is qualified to provide customized services to support your company during all the processes involving API registration and maintenance of the certifications required, facilitating processes, and ensuring health.

CADIFA Lifecycle

CADIFA Lifecycle

Our highly qualified team is dedicated to providing essential support post-approval of CADIFA.
CADIFA Application

CADIFA Application

We are dedicated to providing extensive assistance for your CADIFA application.

CBPF Application

We provide a comprehensive CBPF application service, offering the necessary support throughout the entire process.
Response Application

Response Application

Our highly qualified team stands by your side, providing essential support in the event of receiving a deficiency letter from ANVISA.

Quality Assurance Audit

Our services guarantee that your pharmaceutical operations maintain the highest quality and regulatory compliance Anvisa requires.
Training in Brazilian Pharmaceutical Legislation

Training in Brazilian
Pharmaceutical Legislation

Our training goes beyond theory, combining practical insights with in-depth knowledge of Brazilian pharmaceutical legislation.

Let's talk about how we can assist your company to thrive in the Brazilian market.

News

Recent Posts

CBPF publication – ANVISA Official Gazette of May 6, 2024.

Check the API manufacturing companies that received CBPF (GMP) from ANVISA this week.  The document includes certification issued to biological, semisynthetic, and synthetic API manufacturers—data source: National Health Surveillance Agency – Official Gazette.

CBPF publication – ANVISA Official Gazette of April 29, 2024.

Check the API manufacturing companies that received CBPF (GMP) from ANVISA this week.  The document includes certification issued to biological, semisynthetic, and synthetic API manufacturers—data source: National Health Surveillance Agency – Official Gazette.

CBPF publication – ANVISA Official Gazette of April 22, 2024.

Check the API manufacturing companies that received CBPF (GMP) from ANVISA this week.  The document includes certification issued to biological, semisynthetic, and synthetic API manufacturers—data source: National Health Surveillance Agency – Official Gazette.

CBPF publication – ANVISA Official Gazette of April 15, 2024.

Check the API manufacturing companies that received CBPF (GMP) from ANVISA this week.  The document includes certification issued to biological, semisynthetic, and synthetic API manufacturers—data source: National Health Surveillance Agency – Official Gazette.

CBPF publication – ANVISA Official Gazette of April 8, 2024.

Check the API manufacturing companies that received CBPF (GMP) from ANVISA this week.  The document includes certification issued to biological, semisynthetic, and synthetic API manufacturers—data source: National Health Surveillance Agency – Official Gazette.

CBPF publication – ANVISA Official Gazette of April 1, 2024.

Check the API manufacturing companies that received CBPF (GMP) from ANVISA this week.  The document includes certification issued to biological, semisynthetic, and synthetic API manufacturers—data source: National Health Surveillance Agency – Official Gazette.
plugins premium WordPress